Treatment of lupus erythematosus with mepacrine

scientific article published on 01 October 1951

Treatment of lupus erythematosus with mepacrine is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0140-6736(51)91643-1
P698PubMed publication ID14874500

P2093author name stringF PAGE
P433issue6687
P407language of work or nameEnglishQ1860
P921main subjectlupus erythematosusQ188297
P304page(s)755-758
P577publication date1951-10-01
P1433published inThe LancetQ939416
P1476titleTreatment of lupus erythematosus with mepacrine
P478volume2

Reverse relations

cites work (P2860)
Q69399379A Reappraisal of Oral Quinine in Discoid Lupus Erythematosus
Q50059772A bibliometric review of drug repurposing
Q41946120Amodiaquine and hydroxychloroquine in rheumatoid arthritis
Q39990460An appraisal of chloroquine
Q72636802Antimalarials
Q40332551Antimalarials and ophthalmologic safety
Q39772563Antimalarials in the management of discoid and systemic lupus erythematosus
Q78642719Antimalarials in treatment of Sjogren's syndrome
Q34129797Antimalarials.
Q33853468Antimalarials: unapproved uses or indications
Q73728364Aplastic anaemia following mepacrine treatment of lupus erythematosus
Q73066689Atabrine in the treatment of discoid lupus erythematosus
Q41947452Atebrine and chloroquine/resochin therapy of lupus erythematous and dermatoses due to photosensitivity
Q41945107Bilateral Macular Degeneration Associated with Chloroquine Therapy*
Q35743410Central scotomata following chloroquine therapy
Q41945745Changes in the human electro-retinogram during long-term resochin therapy
Q33570457Chloroquine and rheumatoid arthritis; a short-term controlled trial
Q33570876Chloroquine diphosphate in rheumatoid arthritis. A controlled trial
Q36861541Chloroquine ototoxicity
Q85020598Chloroquine psychosis
Q73713853Chloroquine sulphate in treatment of chronic discoid lupus erythematosus
Q35664483Controversies in the treatment of rheumatoid arthritis
Q40212123Current status of disease-modifying drugs in progressive rheumatoid arthritis
Q37782472Cutaneous lupus erythematosus: Update of therapeutic options
Q36005283Discussion on the collagen vascular diseases
Q34357618Disease modifying drugs for rheumatoid arthritis: yesterday's treatment today or today's treatment tomorrow?
Q55477738Disturbances of pigmentation with chloroquine.
Q91934535Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases
Q41937626Electroretinography in Patients with Connective Tissue Diseases Treated with Hydroxychloroquine
Q97646016Hydroxychloroquine in Dermatology and Beyond: Recent Update
Q40152521Hydroxychloroquine sulfate in rheumatoid arthritis: Long-term response rate and predictive parameters
Q26782822Hydroxychloroquine-related retinal toxicity
Q37827403Hydroxychloroquine: from malaria to autoimmunity
Q76807490LUPUS ERYTHEMATOSUS
Q41947565Light sensitive eruptions treated with atabrine and chloroquine
Q35547553Long-term effectiveness of antimalarial drugs in rheumatic diseases
Q28331277Marrow transplantation for severe aplastic anemia associated with exposure to quinacrine
Q76282617Mepacrine and rheumatoid arthritis
Q37369932Multifocal electroretinography after high dose chloroquine therapy for malaria
Q89285609Neuropsychiatric clinical manifestations in elderly patients treated with hydroxychloroquine: a review article
Q34007922New concepts in antimalarial use and mode of action in dermatology
Q33652585New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents
Q69829422Non-steroidal anti-inflammatory drugs
Q78836545On visual disturbances and eye changes in quinoline therapy of primary chronic articular rheumatism
Q41944252PERIPHERAL NEUROPATHY FOLLOWING CHLOROQUINE THERAPY
Q76497813Photosensitivity Reactions in Various Diseases
Q47874310Quinacrine for extremity melanoma in a mouse model of isolated limb perfusion (ILP).
Q37415122RETINOPATHY DURING CHLOROQUINE THERAPY.
Q41943431RH ANTIBODY FORMATION UNDER THE INFLUENCE OF CHLOROQUINE DIPHOSPHATE AND SODIUM SALICYLATE MEDICATION
Q74658507Rationale for the treatment of lupus erythematosus with antimalarials
Q41929959Recent therapeutic advances in dermatology
Q35645066Remission-inducing drugs in rheumatoid arthritis
Q40162233Remission-inducing therapy in rheumatoid arthritis
Q35764302Response to antimalarial agents in cutaneous lupus erythematosus: a prospective analysis
Q78766793Retinopathy following chloroquine therapy
Q42174496Synthetic antimalarial drug therapy in lupus erythematosus and polymorphous light eruptions.
Q74603497Systemic lupus erythematosus
Q40090535Systemic lupus erythematosus: 25 years of treatment related to immunopathology.
Q35854161THE VALUE AND DANGERS OF ANTIMALARIAL THERAPY IN ARTHRITIS WITH SPECIAL RELATION TO OPHTHALMIC COMPLICATIONS
Q68322558The Gold Standard in Rheumatoid Arthritis
Q41947536The use of chloroquine diphosphate (aralen) and quinacrine (atabrine) hydrochloride in the prevention of polymorphorus light eruptions.
Q35682095The value of chloroquine in rheumatoid disease: a four-year study of continuous therapy
Q73066692Therapeutic assays of the Skin and Cancer Unit of the New York University Hospital. Assay VII-Quinacrine hydrochloride (atabrine hydrochloride) for chronic discoid lupus erythematosus
Q38561490Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases
Q73582114Thrombotic thrombocytopenic purpura; report of a case
Q73066697Treatment of chronic discoid lupus erythematosus with atabrine
Q78372139Treatment of rheumatoid arthritis with chloroquine
Q53569313Treatment of systemic lupus erythematosus: from cod-liver oil to cyclosporin.
Q41921039Use of synthetic antimalarial drugs and other agents for rheumatoid arthritis: Historic and therapeutic perspectives
Q84600129[Antimalarials: an update in rheumatic diseases]
Q79243061[On the neurological syndrome in the framework of lupus erythematosus]

Search more.